NCT01488591UnknownNot Applicable
Biomarker Research for Personalized Medicine in Blood Cancer Patient
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Sponsor
- Inje University
- Enrollment
- 1,000
- Locations
- 1
Study Overview
Brief Summary
The aim of this study :
- Through the study of genes of protein, transporter, translator and epigenome investigating the effect of anti-cancer treatment or the key factor of the MDR (Multidrug resistance) on the blood cancer patients who are under the anti-cancer sork treatment
- Giving a service of anticancer medicine therapeutic drug monitoring (TDM) and genotyping
Study Design
- Study Type
- Observational
- Time Perspective
- Prospective
Eligibility Criteria
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Clinical diagnosis of Hematologic neoplasms
Exclusion Criteria
- Not provided
Investigators
Jae-Gook Shin
Department of Pharmacology and Pharmacogenomics Research Center
Inje University
Study Sites (1)
Loading locations...
Similar Trials
Completed
Not Applicable
A Longitudinal, Observational Biomarker Study in Participants With Primary Sjogren's SyndromeSjögren's SyndromeHealthySicca SyndromeNCT02422407Biogen100
Completed
Not Applicable
Investigation of Specific Protein/Markers in Patients With Osteoarthritis of the Knee Having a Total Knee ReplacementOsteoarthritis of the KneeNCT01611441AstraZeneca125
Unknown
Not Applicable
Diagnostic, Risk Stratification and Prognostic Value of Novel Biomarkers in Patients With Heart FailureHeart FailureNCT03727828Shanghai 10th People's Hospital3,000
Recruiting
Not Applicable
Genetic Biomarker Research for Personalized Therapy of Chorioretinal Neovascular DiseasesDiseases of the eye and adnexaKCT0001055Inje University Busan Paik Hospital1,000
Completed
Not Applicable
Research of Biomarkers in Duchenne Muscular Dystrophy PatientsDuchenne Muscular Dystrophy (DMD)NCT01380964Genethon220